Abstract
A flow-based system with solenoid micro-pumps is proposed for fast simvastatin (SMT) determination in pharmaceutical preparations. The method is based on the inhibition of methyl orange bromination in the presence of the analyte with spectrophotometric detection. A linear response was observed between 5.0 and 35 mg L-1 SMT with a detection limit of 1.2 mg L-1 (99.7% confidence level). The coefficient of variation (n = 20) and sampling rate were estimated as 3.3% and 80 determinations per hour, respectively. Reagents consumption was estimated as 3.5 μg of NaBrO3, 9.5 μg of methyl orange and 400 μg of NaBr per determination, generating 4.5 mL of waste. The results for pharmaceutical samples agreed with those obtained by the reference chromatographic procedure at the 95% confidence level. The procedure is a fast, greener and reliable alternative for SMT determination.
Keywords: Simvastatin, Flow analysis, Multicommutation, Multi-pumping, Spectrophotometry, SMT, pharmaceutical, Vascular diseases, chromatographic, Mechanization
Current Pharmaceutical Analysis
Title:A Multi-pumping Flow System for Fast Spectrophotometric Determination of Simvastatin
Volume: 9 Issue: 1
Author(s): Wanessa R. Melchert, Alex D. Batista, Andreia C. Pereira, Diogo L. Rocha and Fabio R.P. Rocha
Affiliation:
Keywords: Simvastatin, Flow analysis, Multicommutation, Multi-pumping, Spectrophotometry, SMT, pharmaceutical, Vascular diseases, chromatographic, Mechanization
Abstract: A flow-based system with solenoid micro-pumps is proposed for fast simvastatin (SMT) determination in pharmaceutical preparations. The method is based on the inhibition of methyl orange bromination in the presence of the analyte with spectrophotometric detection. A linear response was observed between 5.0 and 35 mg L-1 SMT with a detection limit of 1.2 mg L-1 (99.7% confidence level). The coefficient of variation (n = 20) and sampling rate were estimated as 3.3% and 80 determinations per hour, respectively. Reagents consumption was estimated as 3.5 μg of NaBrO3, 9.5 μg of methyl orange and 400 μg of NaBr per determination, generating 4.5 mL of waste. The results for pharmaceutical samples agreed with those obtained by the reference chromatographic procedure at the 95% confidence level. The procedure is a fast, greener and reliable alternative for SMT determination.
Export Options
About this article
Cite this article as:
R. Melchert Wanessa, D. Batista Alex, C. Pereira Andreia, L. Rocha Diogo and R.P. Rocha Fabio, A Multi-pumping Flow System for Fast Spectrophotometric Determination of Simvastatin, Current Pharmaceutical Analysis 2013; 9 (1) . https://dx.doi.org/10.2174/1573412911309010015
DOI https://dx.doi.org/10.2174/1573412911309010015 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiplatelet Effects of Bioactive Compounds Present in Tomato Pomace
Current Drug Targets Modulation of Cardiac Metabolism During Myocardial Ischemia
Current Pharmaceutical Design Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis
Current Vascular Pharmacology Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets Depression has a Strong Relationship to Alterations in the Immune, Endocrine and Neural System
Current Psychiatry Reviews Regulation of Female Fertility and Identification of Future Contraceptive Targets
Current Pharmaceutical Design Diet and Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Inpatient Care of the HIV Infected Patient in the Highly Active Antiretroviral Therapy (HAART) Era
Current HIV Research Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
CNS & Neurological Disorders - Drug Targets The Obligatory Role of the Acetylcholine-Induced Endothelium-Dependent Contraction in Hypertension: Can Arachidonic Acid Resolve this Inflammation?
Current Pharmaceutical Design Pathogenesis and Management of Hypertension after Kidney Transplantation
Current Hypertension Reviews A Possible Placental Factor for Preeclampsia: sFlt-1
Current Medicinal Chemistry Contemporary Management of Hypertension - How to Optimize Therapy
Cardiovascular & Hematological Disorders-Drug Targets Porphyromonas Gingivalis Antigenic Determinants - Potential Targets for the Vaccine Development against Periodontitis
Infectious Disorders - Drug Targets Interstitial Lung Disease Associated with Collagen Vascular Disease
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Prediction by Pharmacogenetics of Safety and Efficacy of Non-Steroidal Anti- Inflammatory Drugs: A Review
Current Drug Metabolism The Impact of Hypertension in Hemodialysis Patients
Current Hypertension Reviews Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
Current Vascular Pharmacology Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges
Current Drug Safety Critical Congenital Heart Disease in Neonates: A Review Article
Current Pediatric Reviews